Optimizing Investigator Recruitment in Clinical Trials

Report Overview

This report is  based on a survey of 116 pharmaceutical decision-makers specifically responsible for investigator recruitment activities. The report uncovers drivers and barriers in the investigator recruitment process, identifies a gap between what is currently being done and what needs to be done to grow the pool of qualified PIs, outlines leading-edge strategies the industry is using to address these challenges, and discusses the use of CROs – including where they are missing, meeting, and exceeding sponsors’ expectations – to help pharmaceutical professionals optimize their investigator recruitment activities.

What you will learn:

• Key drivers and obstacles in the investigator recruitment process. This allows project teams to prepare for – and mitigate – delays.
• The gap between what’s happening and what’s required to grow the pool of qualified investigators.  Convince internal audiences to invest in growth strategies.
• CRO recruitment effectiveness. Which service providers lead and which lag in the battle to recruit investigators?
• Investigator database quality. Which CROs possess the most productive investigator databases (Overall, Cardiology, CNS, and Oncology)?

Report Contents:

1. Drivers and Obstacles to Investigator Recruitment Success
2. Recruitment Solutions, including: best methods to find new investigators, geographical challenges, and site identification strategies
3. Use of External Service Providers, including: CRO use, CRO site selection effectiveness, and investigator database productivity by therapeutic area